Literature DB >> 1705117

Inhibition of a receptor-operated calcium channel in pig aortic microsomes by cyclic GMP-dependent protein kinase.

L M Blayney1, P W Gapper, A C Newby.   

Abstract

We have further characterized a putative receptor-operated Ca2+ channel that is activated by histamine and guanosine 5'-[beta gamma-imido]triphosphate. Insensitivity to verapamil, diltiazem or nicardipine, but inhibition by Ni2+ and SK&F 96365, further identify the channel with receptor-mediated Ca2+ entry in intact cells. Inhibition of the channel by cyclic-GMP-dependent protein kinase may contribute to vascular relaxation in response to nitrovasodilators.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1705117      PMCID： PMC1149835          DOI： 10.1042/bj2730803

Source DB:  PubMed          Journal:  Biochem J        ISSN： 0264-6021            Impact factor:   3.857


  23 in total

1.  Partial purification and properties of guanosine 3':5'-monophosphate-dependent protein kinase from pig lung.

Authors:  K Nakazawa; M Sano
Journal:  J Biol Chem       Date:  1975-09-25       Impact factor: 5.157

2.  EDRF and cyclic GMP control gating of receptor-operated calcium channels in vascular smooth muscle.

Authors:  T Godfraind
Journal:  Eur J Pharmacol       Date:  1986-07-31       Impact factor: 4.432

Review 3.  Endothelium-derived relaxing factor.

Authors:  T M Griffith; M J Lewis; A C Newby; A H Henderson
Journal:  J Am Coll Cardiol       Date:  1988-09       Impact factor: 24.094

4.  Molecular mechanism of action of the vasoconstrictor peptide endothelin.

Authors:  C Van Renterghem; P Vigne; J Barhanin; A Schmid-Alliana; C Frelin; M Lazdunski
Journal:  Biochem Biophys Res Commun       Date:  1988-12-30       Impact factor: 3.575

5.  Synthetic atrial peptide inhibits intracellular calcium release in smooth muscle.

Authors:  K D Meisheri; C J Taylor; H Saneii
Journal:  Am J Physiol       Date:  1986-01

6.  SK&F 96365, a novel inhibitor of receptor-mediated calcium entry.

Authors:  J E Merritt; W P Armstrong; C D Benham; T J Hallam; R Jacob; A Jaxa-Chamiec; B K Leigh; S A McCarthy; K E Moores; T J Rink
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

7.  Cyclic guanosine monophosphate inhibition of contraction may be mediated through inhibition of phosphatidylinositol hydrolysis in rat aorta.

Authors:  R M Rapoport
Journal:  Circ Res       Date:  1986-03       Impact factor: 17.367

8.  Endothelium-derived relaxing factor inhibits the formation of inositol trisphosphate by rabbit aorta.

Authors:  D Lang; M J Lewis
Journal:  J Physiol       Date:  1989-04       Impact factor: 5.182

9.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.

Authors:  R M Palmer; A G Ferrige; S Moncada
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

10.  Effect of a stimulant of guanylate cyclase, sin 1, on calcium movements and phospholipase C activation in thrombin-stimulated human platelets.

Authors:  M F Simon; H Chap; L Douste-Blazy
Journal:  Biochem Pharmacol       Date:  1988-04-01       Impact factor: 5.858
View more
  4 in total

1.  Histamine H1-receptor-mediated calcium influx in DDT1MF-2 cells.

Authors:  J M Dickenson; S J Hill
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

2.  Nitric oxide co-ordinates the activities of the capacitative and non-capacitative Ca2+-entry pathways regulated by vasopressin.

Authors:  Zahid Moneer; Jeanette L Dyer; Colin W Taylor
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

3.  cGMP reduces the sarcoplasmic reticulum Ca2+ loading in airway smooth muscle cells: a putative mechanism in the regulation of Ca2+ by cGMP.

Authors:  Blanca Bazán-Perkins
Journal:  J Muscle Res Cell Motil       Date:  2011-10-15       Impact factor: 2.698

4.  Vasoconstrictor agonists activate G-protein-dependent receptor-operated calcium channels in pig aortic microsomes.

Authors:  L M Blayney; P W Gapper; A C Newby
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.